ADRENAL TUMOURS

Clinical trials for ADRENAL TUMOURS explained in plain language.

Never miss a new study

Get alerted when new ADRENAL TUMOURS trials appear

Sign up with your email to follow new studies for ADRENAL TUMOURS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo offers hope for kids with Tough-to-Treat cancers

Disease control Recruiting now

This study is for children and teens (ages 3 to 18) with certain solid tumors that have returned or not responded to standard treatment. The tumors must have a specific marker called SSTR. The study combines two drugs: Lutathera (a radioactive drug that targets SSTR) and Olaparib…

Matched conditions: ADRENAL TUMOURS

Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control

Last updated Jun 22, 2026 12:03 UTC

ADRENAL TUMOURS

Get alerted when new ADRENAL TUMOURS trials appear

New drug combo offers hope for kids with Tough-to-Treat cancers